Biotechnology major Biocon today said it has appointed Suresh Subramanian as the Head of the company’s branded formulations (India) business.
“Suresh has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer. Over the years, he has played multiple leadership roles in Business Development, Marketing, Sales and Strategy,” the company said in a statement.
Biocon CMD Kiran Mazumdar-Shaw said: “Suresh has deep expertise in diverse therapy areas including Oncology, Cardiology and Critical Care and has a proven track record of delivering robust business growth. We are sure, under his leadership, our Branded Formulations business will evolve further and become a strong value builder for Biocon.”
Biocon’s Branded Formulations (India) business is a biologics-led, specialty pharma business focused on the chronic therapy areas of diabetes, cancer and autoimmune conditions.